Saxondale
@Saxondale14
Followers
101
Following
9K
Media
120
Statuses
342
Private Investor - just my opinions not investing advice . Small Mcap Pharma and Gold Mining . Small companies - good management - big dreams #FARN #GGP #AVCT
Joined March 2021
I wonder if one of the leading companies making progress in Immunotherapy treatments will be involved in this ? Huge breakthrough happening in this field at the moment with #FARN
bbc.co.uk
Researchers are looking at making immunotherapy a much more effective treatment for cancer.
0
0
5
We are just starting to get a feel of what value to put on the @FaronPharm Bexmarilimab platform . The Bexmab partner deal will be the first of many over the next few years unless an offer comes in that they can't refuse . #solidtumoursnext #Bexcombo
0
0
7
Things are hotting up at @FaronPharm . Well done to all the crew . The countdown to liftoff begins.... #Bex #Farn #Partner
0
0
5
What if our immune system could better fight cancer cells? 🇫🇮 inventors Sirpa and Markku Jalkanen are redefining what's possible at @FaronPharm with a breakthrough in immune technology. Show your support & vote: https://t.co/AN0m5kaWEW
@InFLAMES_Health
#InventorAward #MedTech
0
6
13
All those connected with @FaronPharm must be very proud today . Almost a lifetimes work in order to finally make such a huge difference for future generations . The future looks brighter because of these two . #Bex
0
0
5
“The drug has by now been tested on 250 patients. It would appear to be safe and actually be able to limit the spread of cancer. This is the greatest possible reward for a person who has worked on the research for the whole of their career.” #Bexmarilimab #Clever1 #FARN
Long-term teamwork by Sirpa Jalkanen’s research group is set to culminate in the best possible result, a new drug limiting the spread of cancer. Read the article: https://t.co/spMYPhhRPe
#WorldCancerDay
@SinaTadayonn @InFLAMES_Health
0
0
10
One of Immumotherapies being trialed is Bexmarilimab in combination with azacitidine - Bexmab trial is showing highly encouraging results . Looking forward to P2 data #AML #azacitidine #bex #FARN
WATCH: Naval G. Daver, MD, discusses the unmet needs that still exist in the treatment of #AML. #leusm | @Daver_Leukemia @MDAndersonNews
https://t.co/lba1H3CCtq
0
0
4
Word is spreading ... Bexmarilimab research features in the Januarys edition of Cancer Immunology Research magazine ! #Bexmarilimab #FARN #FARON #MDS #AML #LLS
Read the new priority brief— Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments, by Jenna H. Rannikko et al. https://t.co/78xJwhHzXQ
@MedicityL
0
0
8
Drug development is rich or poor - Finnish company developing a cancer drug got promising results and is now aiming for a market of 170 billion
0
0
1
News article on Bexmarilimab ."Maija Hollmén and her work groups in Turku are researching a unique drug that seems to be effective for hopeless leukemia . " #FARN #Bex #AML #MDS #LLS
"Koehenkilöitä on jonoksi asti" – Maija Hollmén työryhmineen Turussa tutkii ainutlaatuista lääkettä, joka näyttää tehoavan toivottomaan leukemiaan https://t.co/pYTapUKStr
0
0
1
Always good to listen to Markku talking freely . If any company deserves to make an impact , this is one . #FARN #rolemodel
Our #CEO Markku Jalkanen spoke with @BioBossPodcast’s @WsgJohn on his role as #Faron CEO & how his desire to further develop academic research became a reality through #bexmarilimab, our wholly-owned immunotherapy asset. https://t.co/UOBJHjjJsE
0
0
5
Hugely successful data coming from Faron Pharmaceuticals BEXMAB trial . Partner news next ? #Bex #FARN #Orphandrug #AML #LLS
0
0
9
While we wait for an update on trial data from Faron Pharmaceuticals on the 11th - one may hazard a guess that its not too shabby , given they just added all these dates in their calendar . #Bex #AML #Orphandrug #FARN
0
0
5
#FARN Is monster news around the corner ? @FaronPharm will release news next week Oct 11th . #partner #funding #FDA #approval #orphandrug
0
0
7
Roth agreed that $5 billion to $10 billion would be a good value estimate for a midsize M&A transaction. But she also said she’s not “putting a ring fence around the dollar value.” The deal would likely come with a later-stage drug, she added.
0
0
3